USC put it to the test. Here's what held up.
In 2024, USC's School of Pharmacy studied DHM (dihydromyricetin) — the compound behind the before-bed step.
- Peer-reviewed, not hype. Published in Foods — double-blind, placebo-controlled, 321 people.
- 70% less severity. Versus placebo, at p<.001 — real statistical significance.
- Dose is everything. 800mg was the threshold. Most products use 50–100mg and miss it.
- One piece of three. DHM targets the acetaldehyde and GABA side — the full pack covers all three pillars.